So tirzepatide has a slightly higher reporting rate, but both are in the low single digits
Since 2022, the American Diabetes Association has updated its Standards of Care to recommend GLP1 receptor agonists as a firstline therapy for T2D 2 , eroding older and cheaper generics like metformin, which marks a momentous and fundamental change in treatment
By controlling excess pigment activity, they promote a brighter, more even skin tone over time without surface-level bleaching
Diseases 11 (1), 50
Ask your doctor what your A1c should be
A large drop in body weight is compelling, but a large drop accompanied by smaller waists, better glycemic markers, improved lipids, and lower blood pressure is what strengthens the long-term reimbursement story